Page 41 - Read Online

Page 8 of 8 Wagaskar et al. Mini-invasive Surg 2022;6:14 https://dx.doi.org/10.20517/2574-1225.2021.106

17. Antwi S, Everson TM. Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at
diagnosis: a population-based, propensity score analysis. Cancer Epidemiol 2014;38:435-41. DOI PubMed
18. Poelaert F, Verbaeys C, Rappe B, et al. Cytoreductive prostatectomy for metastatic prostate cancer: first lessons learned from the
multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial. Urology 2017;106:146-52. DOI PubMed
19. Wagaskar VG, Mittal A, Sobotka S, et al. Hood technique for robotic radical prostatectomy-preserving periurethral anatomical
structures in the space of Retzius and Sparing the pouch of Douglas, enabling early return of continence without compromising
surgical margin rates. Eur Urol 2021;80:213-21. DOI PubMed
20. Saika T, Miura N, Fukumoto T, Yanagihara Y, Miyauchi Y, Kikugawa T. Role of robot-assisted radical prostatectomy in locally
advanced prostate cancer. Int J Urol 2018;25:30-5. DOI PubMed
21. Tzelepi V, Efstathiou E, Wen S, et al. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and
docetaxel treatment. J Clin Oncol 2011;29:2574-81. DOI PubMed PMC
22. Shemshaki H, Al-Mamari SA, Geelani IA, Kumar S. Cytoreductive radical prostatectomy versus systemic therapy and radiation
therapy in metastatic prostate cancer: a systematic review and meta-analysis. Urologia 2022;89:16-30. DOI PubMed
23. Preisser F, Mazzone E, Nazzani S, et al. Comparison of perioperative outcomes between cytoreductive radical prostatectomy and
radical prostatectomy for nonmetastatic prostate cancer. Eur Urol 2018;74:693-6. DOI PubMed
24. Checcucci E, Amparore D, De Luca S, Autorino R, Fiori C, Porpiglia F. Precision prostate cancer surgery: an overview of new
technologies and techniques. Minerva Urol Nefrol 2019;71:487-501. DOI PubMed
25. Sooriakumaran P. Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomized controlled
feasibility trial. BJU Int 2017;120:E8-E20. DOI PubMed